Liège, Belgium 19 April 2016 – Mithra Pharmaceuticals is pleased to announce the publication of its 2015 Annual Report and the invitation for its Ordinary General Shareholder’s meeting.
The Annual Report which outlines Mithra’s achievements in 2015 includes the following information:
- Overview of Mithra’s R&D pipeline and letter to shareholders;
- Highlights of Mithra’s strategy and outlook for 2016;
- Corporate governance section;
- Financial statements and notes.
François Fornieri, CEO Mithra Pharmaceuticals: “Our 2015 Annual Report highlights the significant milestones Mithra achieved in 2015, a pivotal year in Mithra’s history. It also underlines the efforts and commitment of our teams to support the evolution of Mithra, and more specifically the R&D pillar development of the company.”
This Annual Report is the first Annual Report released by Mithra since its IPO in June 2015. Mithra releases its Annual Report in English and French. In case of interpretation differences, the English version will prevail.
The report is available in English and French and can be downloaded on the website investors.mithra.com as a PDF file.
Ordinary General Shareholder’s meeting
The Ordinary General Shareholder’s meeting of Mithra Pharmaceuticals will be held on 19th May 2016 at 17:00 PM (CEST) in Liège (Belgium). Mithra Pharmaceuticals is pleased to invite its shareholders.
The notice for the Ordinary General Shareholder’s meeting including a description of the formalities to participate in the Meeting is available on the website investors.mithra.com.